Sub-myeloablative Second Transplantations with Haploidentical Donors and Post-Transplant Cyclophosphamide have limited Anti-Leukemic Effects in Pediatric Patients.
Transplant Cell Ther
; 28(5): 262.e1-262.e10, 2022 05.
Article
in En
| MEDLINE
| ID: mdl-35151936
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cell Transplantation
/
Hematologic Neoplasms
Type of study:
Clinical_trials
/
Guideline
Limits:
Child
/
Humans
Language:
En
Journal:
Transplant Cell Ther
Year:
2022
Document type:
Article
Country of publication: